Viewing StudyNCT00434174



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00434174
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2007-02-09

Brief Title: Safety of Everolimus and Pemetrexed in Lung Cancer Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Non Small Cell Lung Cancer
Keywords:
Name View
Pemetrexed View
Lung cancer View
Non small cell lung cancer View
NSCLC View
RAD001 View
Everolimus View
Afinitor View